3 Results for "

npt200-11

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "npt200-11" in MCE Product Catalog:

Cat. No.: HY-145580
CAS No.: 1802518-92-8
Purity:  98.60%
Synonyms: UCB0599; (R)-npt200-11
Target:  

α-synuclein

Research Areas:  

Neurological Disease

Minzasolmin (UCB0599; (R)-NPT200-11) is an orally active, blood-brain-permeable α-synuclein (α-Syn) inhibitor that selectively binds to α-Syn misfolded intermediates (such as oligomers) and inhibits aggregation and fibril formation by regulating their conformational stability. Minzasolmin can reduce the generation of pathological oligomers and block neurotoxic signaling, thereby reducing the abnormal accumulation of α-Syn in the brain. Minzasolmin significantly improved motor deficits, reduced neuroinflammatory markers, and α-Syn-related pathological deposition in transgenic mouse models .
loading...
    loading...
Cat. No.: HY-125287
CAS No.: 1802518-63-3
Purity:  99.87%
Synonyms: (Rac)-UCB0599; npt200-11
Target:  

α-synuclein

Research Areas:  

Neurological Disease

(Rac)-Minzasolmin ((Rac)-UCB0599; NPT200-11) is a blood-brain barrier penetrated alpha-synuclein (ASYN) misfolding inhibitor. (Rac)-Minzasolmin acts on the early stage of ASYN aggregation process, by replacing the membrane-bound oligomers ASYN, allowing them to revert to the monomeric form, while preventing pathological aggregation. (Rac)-Minzasolmin effectively improves the ASYN deposition in the retina and the neuro-pathological indicators in two α-synuclein transgenic mouse models. (Rac)-Minzasolmin can be used for the studies of Parkinson's disease (PD) and dementia with Lewy bodies (DLB) .
loading...
    loading...
Cat. No.: HY-145580A
CAS No.: 1802518-91-7
Purity:  99.36%
Synonyms: (S)-UCB0599; (S)-npt200-11
Target:  

α-synuclein

Research Areas:  

Neurological Disease

(S)-Minzasolmin is an isomer of minzasolmin (HY-145580), an inhibitor of α-synuclein oligomerization .
loading...
    loading...